Everolimus for epilepsy in paediatric tuberous sclerosis complex
- PMID: 30169310
- DOI: 10.1016/S2352-4642(18)30128-7
Everolimus for epilepsy in paediatric tuberous sclerosis complex
Comment on
-
Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial.Lancet Child Adolesc Health. 2018 Jul;2(7):495-504. doi: 10.1016/S2352-4642(18)30099-3. Epub 2018 May 24. Lancet Child Adolesc Health. 2018. PMID: 30169322 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
